MDXH - MDxHealth SA ADR

Momentum: Bearish

Recent News

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne - MDxHealth ( NASDAQ:MDXH )

IRVINE, CA, and HERSTAL, BELGIUM - September 15, 2025 ( GlobeNewswire ) - MDxHealth SA MDXH ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate ...

Neutral

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

GlobeNewswire • 0 minutes ago • score: 0.09

Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from ...

Neutral

MDxHealth SA ( MDXH ) Reports Q2 Loss, Tops Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.10

MDxHealth SA (MDXH) delivered earnings and revenue surprises of -15.38% and +0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Neutral

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change - MDxHealth ( NASDAQ:MDXH ) , Cytek Biosciences ( NASDAQ:CTKB )

Benzinga • 2 months, 1 week ago • score: 0.07

IRVINE, CA, and HERSTAL, BELGIUM - July 3, 2025 ( GlobeNewswire ) - MDxHealth SA MDXH ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee.

Neutral

Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change

GlobeNewswire • 2 months, 1 week ago • score: 0.07

IRVINE, CA, and HERSTAL, BELGIUM - July 3, 2025 ( GlobeNewswire ) - MDxHealth SA ( NASDAQ: MDXH ) ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee.

Neutral

MDxHealth SA ( MDXH ) Reports Q1 Loss, Tops Revenue Estimates

Zacks Commentary • 4 months ago • score: 0.07

MDxHealth SA (MDXH) delivered earnings and revenue surprises of -46.15% and 0.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Bullish

Down -15.22% in 4 Weeks, Here's Why You Should You Buy the Dip in MDxHealth SA ( MDXH )

Zacks Commentary • 6 months, 1 week ago • score: 0.18

MDxHealth SA (MDXH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near ...

Neutral

MDxHealth SA ( MDXH ) Reports Q4 Loss, Tops Revenue Estimates

Zacks Commentary • 6 months, 2 weeks ago • score: 0.04

MDxHealth SA (MDXH) delivered earnings and revenue surprises of 30% and 7.19%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$3.81

52W Low

$1.35

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-501433.88

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.73

EV/Revenue (<3 favorable)

2.28

P/S (TTM) (<3 favorable)

1.77

P/B (<3 favorable)

23.55

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

13.22%

Institutions (25–75% balanced)

43.66%

Shares Outstanding

49,497,300

Float

35,018,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

98,953,000

Gross Profit (TTM)

62,863,000

EPS (TTM)

-0.76

Profit Margin (>10% good)

-0.35%

Operating Margin (TTM) (higher better)

-0.07%

ROE (TTM) (>15% strong)

-15.52%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.20

Momentum

Bearish momentum

Value

0.2815

0.2872

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025